From: Evaluation and treatment of gastrointestinal bleeding in patients taking anticoagulants presenting to the emergency department
FXa Inhibitor
Strength of the last dose
Time from the last dose
<ā8Ā h/ unknown
ā„ā8Ā h
Rivaroxaban
ā¤ā10Ā mg
Low dose
>ā10Ā mg/ unknown
High dose
Apixaban
ā¤ā5Ā mg
>ā5Ā mg/unknown